PMID- 32380365 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20240227 IS - 1873-5835 (Electronic) IS - 0145-2126 (Linking) VI - 93 DP - 2020 Apr 25 TI - Iron overload regulate the cytokine of mesenchymal stromal cells through ROS/HIF-1alpha pathway in Myelodysplastic syndromes. PG - 106354 LID - S0145-2126(20)30059-X [pii] LID - 10.1016/j.leukres.2020.106354 [doi] AB - Iron overload is a significant feature of myelodysplastic syndromes (MDS) patients due to ineffective hematopoiesis and transfusion dependence. Excess iron results in organ dysfunction through the generation of reactive oxygen species (ROS) which can cause oxidative stress even mutation. Mesenchymal stromal cells (MSCs) are responsible for supporting and regulating hematopoiesis, whether MSCs is involved in the pathogenesis of MDS still need further elucidation. Hypoxia-inducible factors-1 (HIF-1) is an integral signal of inflammation that has been shown to up-regulating in MDS patient. We found that MDS-derived MSC had disorganized clones and increased level of apoptosis (n = 53). Iron transportation-related gene, such as DMT1 and ZIP14, and ROS level were increased in iron overload-MDS-MSC (n = 23). HIF-1a, as a crucial part of HIF-1, was also elevated in iron overload-group and PHD2 involved in the degradation of HIF-1a was reduced. Furthermore, HIF-1 downstream cytokines such IL-6, IL-8, TGF-betaand VEGF that were also involved in the pathogenesis of MDS were increased in IO-MDS-MSC. When treated with DFO and NAC for iron chelation and antioxidation, the level of HIF-1a and related cytokines could decrease. We conclude that iron overload regulates the cytokine of mesenchymal stromal cells through ROS/HIF-1alpha pathway in Myelodysplastic syndromes, result in dysfunction of MSC and damage of microenvironment that may be involved in the pathogenesis of MDS. CI - Copyright (c) 2020. Published by Elsevier Ltd. FAU - Hu, Jiaxin AU - Hu J AD - Department of Hematology, Taianjin Medical University General Hospital, 154 Anshan Street, Heping District, Tianjin 300070, PR China. FAU - Meng, Fanqiao AU - Meng F AD - Department of Hematology, Taianjin Medical University General Hospital, 154 Anshan Street, Heping District, Tianjin 300070, PR China. FAU - Hu, Xian AU - Hu X AD - Department of Hematology, Taianjin Medical University General Hospital, 154 Anshan Street, Heping District, Tianjin 300070, PR China. FAU - Huang, Lei AU - Huang L AD - Department of Hematology, Taianjin Medical University General Hospital, 154 Anshan Street, Heping District, Tianjin 300070, PR China. FAU - Liu, Hui AU - Liu H AD - Department of Hematology, Taianjin Medical University General Hospital, 154 Anshan Street, Heping District, Tianjin 300070, PR China. FAU - Liu, Zhaoyun AU - Liu Z AD - Department of Hematology, Taianjin Medical University General Hospital, 154 Anshan Street, Heping District, Tianjin 300070, PR China. FAU - Li, Lijuanli AU - Li L AD - Department of Hematology, Taianjin Medical University General Hospital, 154 Anshan Street, Heping District, Tianjin 300070, PR China. Electronic address: lilijuan20@qq.com. LA - eng PT - Journal Article DEP - 20200425 PL - England TA - Leuk Res JT - Leukemia research JID - 7706787 SB - IM OTO - NOTNLM OT - Hypoxia inducible factor-1 OT - Iron overload OT - Mesenchymal stromal cells OT - Myelodysplastic syndromes COIS- Declaration of Competing Interest There are no competing interests among authors. EDAT- 2020/05/08 06:00 MHDA- 2020/05/08 06:01 CRDT- 2020/05/08 06:00 PHST- 2020/03/07 00:00 [received] PHST- 2020/04/10 00:00 [revised] PHST- 2020/04/13 00:00 [accepted] PHST- 2020/05/08 06:01 [medline] PHST- 2020/05/08 06:00 [pubmed] PHST- 2020/05/08 06:00 [entrez] AID - S0145-2126(20)30059-X [pii] AID - 10.1016/j.leukres.2020.106354 [doi] PST - aheadofprint SO - Leuk Res. 2020 Apr 25;93:106354. doi: 10.1016/j.leukres.2020.106354.